Market Overview:
The global cardiovascular stent market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in stent technology, and rising demand for minimally invasive procedures. Based on type, the global cardiovascular stent market is segmented into drug eluting stents (DES), bioresorbable stents (BRS), metal stents (MS), and others.
Product Definition:
A cardiovascular stent is a medical device that is used to open up narrowed or blocked blood vessels in the heart. This device helps improve blood flow and can help prevent heart attacks and strokes.
Drug Eluting Stents:
A drug eluting stent is a medical device used to treat coronary artery disease by reducing the formation of blood clots in the arteries. Drug-eluting stents are also known as bioresorbable or bioabsorbable stents and have gained popularity over conventional metal stents due to their ability to reduce adverse effects such as restenosis (reoccurrence of symptoms) and repeat revascularization (reopening of an artery).
Bioresorbable Stents:
Bioresorbable stents are a new class of biodegradable stents that are currently under investigation in clinical trials. These devices have the potential to reduce the need for surgical removal and may offer an alternative to traditional metal or polymer-based biodegradable stents. The primary objective of these studies is to demonstrate safety and efficacy in patients with advanced coronary artery disease, which is being challenged by a growing number of people suffering from cardiovascular diseases globally.
Application Insights:
Based on the application, the global cardiovascular stent market is segmented into hospitals, ambulatory surgery centers, special clinics and others. The hospitals segment dominated the overall market in terms of revenue in 2017. This high share is attributable to factors such as a large patient base with multiple diseases requiring cardiac intervention and advanced healthcare facilities with highly skilled personnel for complex surgeries.
The special clinics application segment was estimated to be worth over USD 1 billion in 2017 owing to increasing adoption of these devices for treatment due to low risk profile associated with this population along with growing awareness about available treatments among individuals who have never had any heart related issues or symptoms before. These factors are expected to drive growth over the forecast period thus contributing towards significant market size by 2030.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a well-developed healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies. Moreover, increasing incidence of cardiovascular diseases is also expected to drive growth during the forecast period. According to data published by CDC in 2016’s annual Report on Trends in Disease Prevalence, heart disease and stroke remain among leading causes of death across U.S., accounting for around 795,000 deaths annually.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising geriatric population with chronic conditions such as cardiac disorders coupled with improving economic status resulting into higher penetration rates for innovative products such as coronary stents that are likely saving lives every day.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Rising geriatric population
- Growing demand for minimally invasive procedures
- Technological advancements in stent design and delivery systems
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiovascular Stent Market Research Report
By Type
Drug Eluting Stents, Bioresorbable Stents, Metal Stents, Others
By Application
Hospitals, Ambulatory Surgery Centers, Special Clinics, Others
By Companies
Biotronik, Cardinal Health, BD, MicroPort Scientific Corporation, Terumo, B. Braun Holding, Abbott, Boston Scientific Corporation, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Cardiovascular Stent Market Report Segments:
The global Cardiovascular Stent market is segmented on the basis of:
Types
Drug Eluting Stents, Bioresorbable Stents, Metal Stents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgery Centers, Special Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biotronik
- Cardinal Health
- BD
- MicroPort Scientific Corporation
- Terumo
- B. Braun Holding
- Abbott
- Boston Scientific Corporation
- Medtronic
Highlights of The Cardiovascular Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drug Eluting Stents
- Bioresorbable Stents
- Metal Stents
- Others
- By Application:
- Hospitals
- Ambulatory Surgery Centers
- Special Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiovascular Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A cardiovascular stent is a small, metal tube that is inserted into the artery to help maintain blood flow. If the artery becomes blocked, a cardiovascular stent can open up the narrowed area and restore normal blood flow.
Some of the major players in the cardiovascular stent market are Biotronik, Cardinal Health, BD, MicroPort Scientific Corporation, Terumo, B. Braun Holding, Abbott, Boston Scientific Corporation, Medtronic.
The cardiovascular stent market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cardiovascular Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cardiovascular Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cardiovascular Stent Market - Supply Chain
4.5. Global Cardiovascular Stent Market Forecast
4.5.1. Cardiovascular Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cardiovascular Stent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cardiovascular Stent Market Absolute $ Opportunity
5. Global Cardiovascular Stent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cardiovascular Stent Market Size and Volume Forecast by Type
5.3.1. Drug Eluting Stents
5.3.2. Bioresorbable Stents
5.3.3. Metal Stents
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cardiovascular Stent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cardiovascular Stent Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory Surgery Centers
6.3.3. Special Clinics
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cardiovascular Stent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cardiovascular Stent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cardiovascular Stent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cardiovascular Stent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cardiovascular Stent Demand Share Forecast, 2019-2026
9. North America Cardiovascular Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cardiovascular Stent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cardiovascular Stent Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory Surgery Centers
9.4.3. Special Clinics
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cardiovascular Stent Market Size and Volume Forecast by Type
9.7.1. Drug Eluting Stents
9.7.2. Bioresorbable Stents
9.7.3. Metal Stents
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cardiovascular Stent Demand Share Forecast, 2019-2026
10. Latin America Cardiovascular Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cardiovascular Stent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cardiovascular Stent Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Special Clinics
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cardiovascular Stent Market Size and Volume Forecast by Type
10.7.1. Drug Eluting Stents
10.7.2. Bioresorbable Stents
10.7.3. Metal Stents
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cardiovascular Stent Demand Share Forecast, 2019-2026
11. Europe Cardiovascular Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cardiovascular Stent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cardiovascular Stent Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Special Clinics
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cardiovascular Stent Market Size and Volume Forecast by Type
11.7.1. Drug Eluting Stents
11.7.2. Bioresorbable Stents
11.7.3. Metal Stents
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cardiovascular Stent Demand Share, 2019-2026
12. Asia Pacific Cardiovascular Stent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cardiovascular Stent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cardiovascular Stent Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Special Clinics
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cardiovascular Stent Market Size and Volume Forecast by Type
12.7.1. Drug Eluting Stents
12.7.2. Bioresorbable Stents
12.7.3. Metal Stents
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cardiovascular Stent Demand Share, 2019-2026
13. Middle East & Africa Cardiovascular Stent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cardiovascular Stent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cardiovascular Stent Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Special Clinics
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cardiovascular Stent Market Size and Volume Forecast by Type
13.7.1. Drug Eluting Stents
13.7.2. Bioresorbable Stents
13.7.3. Metal Stents
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cardiovascular Stent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Cardiovascular Stent Market: Market Share Analysis
14.2. Cardiovascular Stent Distributors and Customers
14.3. Cardiovascular Stent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Biotronik
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cardinal Health
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BD
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. MicroPort Scientific Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Terumo
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. B. Braun Holding
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Abbott
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Boston Scientific Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medtronic
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
